Project Management

Steve Atkinson

Scientific Alliances, Business Development

ab88jj@r.postjobfree.com

Summary

Pharmaceutical licensing scientist with a strong technical, research and development background. Strengths

include identifying and evaluating in-licensing opportunities across all therapeutic areas including neuroscience,

cardio-pulmonary, anti-infectives, inflammation, oncology and technology. Experience and interests lie in

enhancing the effectiveness of teams in a global environment. I have extensive experience managing

cross-functional assessment teams, applying a wide portfolio of tools and approaches in analytical and process

improvement, project management and general consultancy for analysis for New Business prospects. Expertise

includes:

Scientific Assessment, Project Implementation/ Management, Competitive Intelligence, Due Diligence,

Financial Forecast Models, Global Alliances, Deal/Contract Negotiation, Business Development, SWOT

Analysis, Drug’s Lifecycle

Specialties

Ability to lead / manage projects successfully. Strong consultation skills, conflict resolution and negotiation

skills. Solid knowledge/experience of knowledge management and collaborative tools. Ability to apply risk

assessment to a strategic plan. Effective oral/presentation and written communication skills. Project

management skills. Understands budgeting and P&L forecasting. Computer skills and technical knowledge of

several scientific databases.

Experience

Manager, Scientific Alliances at BHR Pharma

June 2009 - May 2013 (4 years)

•Secured partnerships which delivered value to BHR Pharma and Besins Healthcare corporate growth.

•Identified, evaluated and executed opportunities to in-licenses and out-license company’s products and

intellectual property. Worked cross functionally to execute on the business development process and

champion teams to bring deals to closure.

.•Managed the internal cross-functional scientific review and marketing/financial feasibility process; analyzed

investment and partnership opportunities including mergers & acquisitions, in-licensing, out-licensing,

international expansion, co-promotion, and R&D risk sharing.

•Provided scientific and commercial competitive analysis support for any product licensing. Providing a

strategic assessment of the competitive landscape and scientific evaluation of the drug development pipelines.

Senior Scientist - Oncology Drug Discovery at GlaxoSmithKline

December 2004 - December 2008 (4 years 1 month)

Senior Scientist, Oncology, Medicinal drug research and discovery. Designed and synthesized target specific

Page1

receptor Inhibitors for disease therapy in oncology. Interpretation and understanding of all biological data to

provide quality drug candidates for Human Clinical trials (Phase II). Participated on a Project Team that

discovered and delivered four kinase-inhibitors for Clinical Phase I testing. Helped create a novel molecular

series for the next generation of kinase-inhibitors for candidate selection. Knowledgeable in the current

analytical separation techniques, purifications and characterization of small molecules. Managed the Project

Team’s competitive intelligence reports consisting of the Therapeutic Area’s landscaping and current updates

of the competitor’s patents and publications.

Senior Due Diligence Scientist, Business Development at Eli Lilly

June 2002 - July 2004 (2 years 2 months)

Identified and evaluated in-licensing opportunities across all therapeutic areas for the enhancement of the

product pipeline and to help drive research and development by the acquisition of novel technology and

scientific assets. Drove the in-licensing process and maintained in depth knowledge of external pipelines and

provided timely and cogent analyses to senior management. Managed and instructed cross-functional

scientific teams through the due diligence process, developed timelines and advised teams on final reports for

Senior Management consideration. Contributed more than $10,000,000 of expected economic value for

in-licensing deals and over $1,000,000 for out-licensing deals signed. Managed teams in 6 successful

In-Licensing acquisition or collaboration deals that contributed to the 20% of external alliances in the R&D

pipeline.

Patent Research Scientist at Eli Lilly

June 2000 - June 2002 (2 years 1 month)

Administered Intellectual Property (IP) Portfolios and Publications.

Acted as a liaison between the patent attorneys and scientists for IP documentations. Participated in

managing Product team’s product extensions and life-cycle portfolio, Gemzar® and Alimta®. Gathered and

managed scientific and intelligence information. Managed several oncology portfolios for attorneys and the

cross-functional teams. Gathered and evaluated competitive intelligence and information from patent and

scientific literature of competitors; summarized for patent attorney, team, and Portfolio Committees.

Organized relevant patent and scientific literature for opinions and patent preparations, prosecutions and

litigation activities. Proficient in scientific searchable databases; STN-CAS On-line, SciFinder, MicroPatent,

Derwent, MDL-Crossfire, Ovid, Lexis/Nexis and other search engines.

Senior Organic Chemist at Eli Lilly and Company

1998 - 2000 (2 years)

Rationale design and synthesis of 5HT2A/SSRI Antagonist CNS compounds and MC4 Receptor Agonists.

Medicinal Chemist at GlaxoSmithKline (SmithKline and Beecham)

1992 - 1998 (6 years)

Designed and synthesized of Endothelin Receptor Antagonists Compounds.

Page2

Languages

German (read only)

Skills & Expertise

Life Sciences

Neuroscience

Oncology

Competitive Intelligence

Licensing

Business Alliances

Project Management

Financial Modeling

Due Diligence

Clinical Development

Education

University of Virginia

Graduate School, Medicinal/Organic Chemistry

Page3

Steve Atkinson

Scientific Alliances, Business Development

ab88jj@r.postjobfree.com

Contact Steve on LinkedIn

Page4

Contact this candidate